EURX Eurand N.V. (MM)

Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, announced today that it is scheduled to present at the upcoming Cowen Health Care Conference. John Fraher, Eurand's Chief Commercial Officer, will be presenting.

Event: Cowen Health Care Conference
Date: Wednesday, March 10, 2010
Time: 11:00 a.m. ET
Location:  Boston Marriott Copley Place Hotel, Boston, Mass.

An audio webcast of the presentation will be available by accessing the investor relations section of Eurand's web site at www.eurand.com. A replay of the presentation will be available for 30 days.

About Eurand

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had six products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles and taste-masking/ orally disintegrating tablet (ODT) formulations.

Eurand is a global company with facilities in the U.S. and Europe. For more information, visit Eurand's website at www.eurand.com.

Contacts: Bill Newbould Vice President, Investor Relations Eurand N.V. +1 267-759-9335 Email Contact Nick Laudico/Sara Pellegrino The Ruth Group +1 646-536-7030/7002 Email Contact Email Contact